Cargando…
Intelligent Nanoparticles With pH-Sensitive Co-Delivery of Temozolomide and siEGFR to Ameliorate Glioma Therapy
Glioblastoma (GBM) is one of the most lethal forms of human cancer, with very few long-term survivors. In addition to surgery, chemotherapy is still an important strategy. Unfortunately, GBM chemotherapy faces two main challenges: first, in GBM, epidermal growth factor receptor (EGFR) overexpression...
Autores principales: | Wang, Zhen, Liu, Yuyang, Xiao, Yong, Xie, Yandong, Wang, Ran, Zhang, Yiding, Zhou, Qi, Liu, Liang, Sun, Shuo, Xiao, Hong, Zou, Yuanjie, Yang, Kun, Li, Xiang, Zhao, Mengjie, Hu, Yifang, Liu, Hongyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315344/ https://www.ncbi.nlm.nih.gov/pubmed/35903366 http://dx.doi.org/10.3389/fgene.2022.921051 |
Ejemplares similares
-
Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma
por: Shi, Hui, et al.
Publicado: (2020) -
Construction of a novel radiosensitivity- and ferroptosis-associated gene signature for prognosis prediction in gliomas
por: Xie, Yandong, et al.
Publicado: (2022) -
Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
por: Peng, Yuan, et al.
Publicado: (2018) -
The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma
por: Xu, Haoyue, et al.
Publicado: (2022) -
Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH
por: Rao, Jyotsna U., et al.
Publicado: (2017)